Canary Rx

Canary Rx is a Canadian licensed cannabis producer operating a 44,000-square-foot cultivation and processing facility in Norfolk County, Ontario. The company focuses on cultivation, processing, wholesale distribution, and sales of cannabis products under Health Canada licenses, and has also described plans to support third-party processing and co-packing services. Canary Rx became part of Target Group through Target's 2018 acquisition of Visava, which owned Canary Rx. Public disclosures indicate the business has operated as a wholly owned subsidiary of Target Group and has sold cannabis into Canadian wholesale channels. Based on available information, Canary Rx is best characterized as a commercial-stage cannabis producer rather than a traditional biotech or therapeutic drug-development company.